The global fosfomycin calcium API market is expected to grow at a CAGR of XX% during the forecast period. The growth of this market can be attributed to the increasing prevalence of antibiotic-resistant bacteria and increasing demand for fosfomycin calcium API. Fosfomycin is an antibiotic that has been used in the treatment of urinary tract infections, respiratory tract infections, and other bacterial infections. It is also used as a prophylactic agent in patients with cystic fibrosis who are colonized with P. aeruginosa or other gram-negative organisms. Fosfomycin has been found to be effective against many strains of bacteria that are resistant to other antibiotics such as penicillin, amoxicillin, erythromycin, tetracycline, ciprofloxacin and levofloxacin.
North America accounted for the largest share in terms of revenue generated from sales in 2017 owing to its large population base and high awareness about healthcare products among people residing there. Europe followed North America closely owing to its high adoption rate for new technologies across various industries including healthcare industry which led it towards adopting newer technologies such as fosfomycin calcium API more quickly than any other region globally.
- Fosfomycin is a broad-spectrum antibiotic that is used to treat urinary tract infections, intra-abdominal infections, and other bacterial infections.
- Fosfomycin has been shown to be effective against many strains of bacteria that are resistant to other antibiotics such as penicillin and amoxicillin.
- The drug is not absorbed from the gastrointestinal tract and must be given intravenously or intramuscularly for systemic use.
- Fosfomycin has been shown to have a low potential for development of resistance in bacteria, which may make it an attractive alternative treatment option for patients with multi-drug resistant bacterial infections.
- The drug can be used in combination with other antibiotics when appropriate.
Industry Growth Insights published a new data on “Fosfomycin Calcium API Market”. The research report is titled “Fosfomycin Calcium API Market research by Types (0.98, 0.99, Others, ), By Applications (Medical, Microbiology, Others, ), By Players/Companies Northeast Pharm, Manus Aktteva Biopharma LLP, Shinpoong Pharm, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fosfomycin Calcium API Market Research Report
By Type
0.98, 0.99, Others,
By Application
Medical, Microbiology, Others,
By Companies
Northeast Pharm, Manus Aktteva Biopharma LLP, Shinpoong Pharm, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Fosfomycin Calcium API Market Report Segments:
The global Fosfomycin Calcium API market is segmented on the basis of:
Types
0.98, 0.99, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Microbiology, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Northeast Pharm
- Manus Aktteva Biopharma LLP
- Shinpoong Pharm
- Hubei Xunda Pharmaceutical
- Guangxi Nanning Baihui Pharmaceutical
- Shanxi Dongjin Pharmaceutical Co., Ltd.
- Shanghai Wuzhou Pharmaceutical
- Shanghai Xinya Pharmaceutical
Highlights of The Fosfomycin Calcium API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.98
- 0.99
- Others
- By Application:
- Medical
- Microbiology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fosfomycin Calcium API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fosfomycin calcium API is a white to off-white powder that is soluble in water and slightly soluble in alcohol. It has a molecular weight of 568.4 and a chemical formula of C8H10N4O2S.
Some of the key players operating in the fosfomycin calcium api market are Northeast Pharm, Manus Aktteva Biopharma LLP, Shinpoong Pharm, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fosfomycin Calcium API Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fosfomycin Calcium API Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fosfomycin Calcium API Market - Supply Chain
4.5. Global Fosfomycin Calcium API Market Forecast
4.5.1. Fosfomycin Calcium API Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fosfomycin Calcium API Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fosfomycin Calcium API Market Absolute $ Opportunity
5. Global Fosfomycin Calcium API Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fosfomycin Calcium API Market Size and Volume Forecast by Type
5.3.1. 0.98
5.3.2. 0.99
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fosfomycin Calcium API Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fosfomycin Calcium API Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Microbiology
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fosfomycin Calcium API Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fosfomycin Calcium API Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fosfomycin Calcium API Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fosfomycin Calcium API Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fosfomycin Calcium API Demand Share Forecast, 2019-2026
9. North America Fosfomycin Calcium API Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fosfomycin Calcium API Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fosfomycin Calcium API Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Microbiology
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fosfomycin Calcium API Market Size and Volume Forecast by Type
9.7.1. 0.98
9.7.2. 0.99
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fosfomycin Calcium API Demand Share Forecast, 2019-2026
10. Latin America Fosfomycin Calcium API Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fosfomycin Calcium API Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fosfomycin Calcium API Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Microbiology
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fosfomycin Calcium API Market Size and Volume Forecast by Type
10.7.1. 0.98
10.7.2. 0.99
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fosfomycin Calcium API Demand Share Forecast, 2019-2026
11. Europe Fosfomycin Calcium API Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fosfomycin Calcium API Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fosfomycin Calcium API Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Microbiology
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fosfomycin Calcium API Market Size and Volume Forecast by Type
11.7.1. 0.98
11.7.2. 0.99
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fosfomycin Calcium API Demand Share, 2019-2026
12. Asia Pacific Fosfomycin Calcium API Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fosfomycin Calcium API Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fosfomycin Calcium API Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Microbiology
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fosfomycin Calcium API Market Size and Volume Forecast by Type
12.7.1. 0.98
12.7.2. 0.99
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fosfomycin Calcium API Demand Share, 2019-2026
13. Middle East & Africa Fosfomycin Calcium API Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fosfomycin Calcium API Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fosfomycin Calcium API Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Microbiology
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fosfomycin Calcium API Market Size and Volume Forecast by Type
13.7.1. 0.98
13.7.2. 0.99
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fosfomycin Calcium API Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fosfomycin Calcium API Market: Market Share Analysis
14.2. Fosfomycin Calcium API Distributors and Customers
14.3. Fosfomycin Calcium API Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Northeast Pharm
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Manus Aktteva Biopharma LLP
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shinpoong Pharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hubei Xunda Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Guangxi Nanning Baihui Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shanxi Dongjin Pharmaceutical Co., Ltd.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shanghai Wuzhou Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanghai Xinya Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
